Reports
| Status | Drug name | NICE TAs | Comments |
|---|---|---|---|
|
Eliglustat (Cerdelga®) |
NHSE commissioned |
|
|
|
Elosulfase lfa (Vimizim®) |
NHSE commissioned |
|
|
Eluxadoline (Truberzi®) |
To be used in line with NICE TA 471. Specialist initiation, and transfer prescribing to GP using RICaD (in development). |
|
|
|
Enalapril tablets |
For existing patients only |
|
|
|
Enoxaparin Injection |
For all other indications. The APC's view is that on clinical grounds, the status for certain indications approved by APC should be amber, supported by an ESCA. However, until the commissioning arrangements have been agreed to allow safe transfer of patient care, the status will remain red (ESCAs to be developed). |
|
|
|
Enzalutamide capsules#8.3 |
For hospital use only |
|
|
|
Eosin solution 2% w/v |
Unlicensed special |
|
|
|
Ephedrine injection |
Hospital use only |
|
|
Ephedrine nose drops 0.5% and 1% drops |
Short term use only |
|
|
|
Epirubicin injection |
For hospital use only |
- First page
- Previous page
- 1
- 2
- 3
- 4
- 5
- 6
- 7
- 8
- 9
- 10
- 11
- 12
- 13
- 14
- 15
- 16
- 17
- 18
- 19
- 20
- 21
- 22
- 23
- 24
- 25
- 26
- 27
- 28
- 29
- 30
- 31
- 32
- 33
- 34
- 35
- 36
- 37
- 38
- 39
- 40
- 41
- 42
- 43
- 44
- 45
- 46
- 47
- 48
- 49
- 50
- 51
- 52
- 53
- 54
- 55
- 56
- 57
- 58
- 59
- 60
- 61
- 62
- 63
- 64
- 65
- 66
- 67
- 68
- 69
- 70
- 71
- 72
- 73
- 74
- 75
- 76
- 77
- 78
- 79
- 80
- 81
- 82
- 83
- 84
- 85
- 86
- 87
- 88
- 89
- 90
- 91
- 92
- 93
- 94
- 95
- 96
- 97
- 98
- Next page
- Last page
